AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2009

Jul 29, 2009

34915_dirs_2009-07-29_9e775bf6-78ca-48e7-a246-5cd7ab9127d2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2009-07-27

Reporting Person: Theracour Pharma, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-07-27	Common Stock	S	12000	$0.74	Disposed	34671400	Direct
2009-07-28	Common Stock	S	19500	$.74	Disposed	34651900	Direct

Footnotes

F1: Represents shares of common stock sold in accordance with TheraCour's Rule 10b5-1 Trading Plan adopted with the Registrant as disclosed on Form 8-K on February 10, 2009.